IHL
BHVN

Investment House LLC’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Investment House LLC’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,425
Closed -$367K – 186
2022
Q3 		$367K Sell
2,425
-3,010
-55% -$446K 0.03% 146
2022
Q2 		$792K Hold
5,435
– – 0.07% 108
2022
Q1 		$644K Hold
5,435
– – 0.05% 125
2021
Q4 		$749K Sell
5,435
-1,750
-24% -$223K 0.05% 126
2021
Q3 		$998K Hold
7,185
– – 0.07% 115
2021
Q2 		$697K Hold
7,185
– – 0.05% 135
2021
Q1 		$491K Sell
7,185
-575
-7% -$46.5K 0.04% 143
2020
Q4 		$665K Buy
7,760
+360
+5% +$30.5K 0.05% 143
2020
Q3 		$481K Buy
7,400
+600
+9% +$39.3K 0.04% 143
2020
Q2 		$497K Buy
+6,800
New +$362K 0.04% 136

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Investment House LLC's BHVN Position: Q4 2022 in Review

Investment House LLC sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 2,425 shares — an estimated $367K sold.

Investment House LLC first reported a position in BHVN in Q2 2020 and held it in 10 quarters. The position peaked at $998K in Q3 2021. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Investment House LLC reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Investment House LLC sold 2,425 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $367K.
  • Investment House LLC first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2020 and held it in 10 quarters.
  • Investment House LLC's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $998K in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Investment House LLC's 13F filing for Q4 2022, filed 7 Feb 2023.